Filtered By:
Condition: Heart Valve Disease

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 554 results found since Jan 2013.

Transcatheter Aortic Valve Replacement Through a Single Femoral Access: A Multicenter Experience
CONCLUSIONS: An all-in-one access technique allows safe implantation of Acurate neo and neo2 transcatheter heart valves, with low rates of periprocedural complications and favorable short-term outcomes.PMID:36121924
Source: The Journal of Invasive Cardiology - September 19, 2022 Category: Cardiology Authors: Stefan Toggweiler Rodrigo Bagur Carla Romina Agatiello Carlos Giuliani Federico Moccetti Pantelis Diamantouros Horacio Medina de Chazal Ignacio Miguel Seropian Mathias Wolfrum Matias Sztejfman Source Type: research

Association between Acid-Suppressive Drugs and Clinical Outcomes in Patients with Nonvalvular Atrial Fibrillation
ConclusionsASDs were significantly associated with all-cause mortality in patients with NVAF taking OACs.
Source: Drugs in R&D - July 19, 2022 Category: Drugs & Pharmacology Source Type: research

Heart surgery and simultaneous carotid endarterectomy - 10-years single-center experience
CONCLUSION: Within the reported patient population of coronary artery heart disease and significant internal carotid stenosis, a one-time approach with CABG or heart-valve surgery and CEA is safe and feasible as justified by clinical and neurological postoperative outcomes.PMID:35841145 | DOI:10.1177/02676591221114953
Source: Perfusion - July 16, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Stephen Gerfer Borko Ivanov Ihor Krasivskyi Ilija Djordjevic Christopher Gaisendrees Soi Avgeridou Ferdinand Kuhn-R égnier Navid Mader Parwis Rahmanian Axel Kr öner Elmar Kuhn Thorsten Wahlers Source Type: research

Effect of β‐blocker on patients with moderate functional mitral regurgitation undergoing surgical aortic valve replacement
ConclusionsThe administration of BB after SAVR was not associated with lower risk of MACCE for patients of severe aortic valve disease complicated with moderate FMR, but was potentially beneficial for improving FMR.
Source: ESC Heart Failure - July 13, 2022 Category: Cardiology Authors: Xieraili Tiemuerniyazi, Yifeng Nan, Yangwu Song, Ziang Yang, Wei Zhao, Fei Xu, Wei Feng Tags: Original Article Source Type: research

A Review of the Role of Transthoracic and Transesophageal Echocardiography, Computed Tomography, and Magnetic Resonance Imaging in Cardioembolic Stroke
Med Sci Monit. 2022 Jun 22;28:e936365. doi: 10.12659/MSM.936365.ABSTRACTStroke is a major source of morbidity and mortality worldwide, accounting for the second largest cause of mortality and the third greatest cause of disability. Stroke is frequently preceded by a transient ischemic attack (TIA). The etiologies of 20-30% of ischemic strokes are unknown, and thus are termed "cryptogenic strokes". About 25% of ischemic strokes are cardioembolic. Strokes occur at a rate of around 2% per year in individuals with heart failure with reduced ejection fraction (HFrEF), with a strong correlation between stroke risk and the degree...
Source: Medical Science Monitor - June 22, 2022 Category: Research Authors: Sergiu Florin Arnautu Diana Aurora Arnautu Ana Lascu Andrei A Hajevschi Ciprian Ilie Ilie Rosca Abhinav Sharma Dragos Catalin Jianu Source Type: research

Severe Libman –Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases
ConclusionSevere HVD leading to surgery was strongly associated with thrombotic APS, especially arterial phenotypes. Half of the reported patients presented cerebral stroke complicating the HVD. Valvular surgery carried a significant risk of CAPS.
Source: Rheumatology - June 10, 2022 Category: Rheumatology Source Type: research

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

Efficacy and Safety of Postdilation for a Self-Expanding Transcatheter Heart Valve
CONCLUSION: For transfemoral TAVR using the Acurate neo/neo2, BPD effectively reduces relevant PVR and decreases the risk of PPM without increasing adverse events. Transcatheter heart valve damage associated with BPD is rare, commonly avoidable, and does not jeopardize the net benefit of BPD.PMID:35593542
Source: The Journal of Invasive Cardiology - May 20, 2022 Category: Cardiology Authors: Won-Keun Kim Matthias Renker Holger Nef Helge M öllmann Thomas Walther Yeong-Hoon Choi Christian W Hamm Source Type: research